Del Rivero, Jaydira <br/><br/>
Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.  [electronic resource] 

 -  The oncologist  01 2019 
 - 16-e14 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-490X 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.2018-0452  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Bortezomib--pharmacology<br/>Carcinoma, Neuroendocrine--diet therapy<br/>Female<br/>Humans<br/>Male<br/>Piperidines--pharmacology<br/>Proto-Oncogene Mas<br/>Quinazolines--pharmacology<br/>Thyroid Neoplasms--diet therapy